Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Alacepril (DU-1219) is a relatively novel angiotensin-converting enzyme inhibitor, used as an antihypertensive
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 50.00 | |
25 mg | In stock | $ 81.00 | |
50 mg | In stock | $ 122.00 | |
100 mg | In stock | $ 182.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 55.00 |
Description | Alacepril (DU-1219) is a relatively novel angiotensin-converting enzyme inhibitor, used as an antihypertensive |
In vivo | Treatment with alacepril improves functional status and exercise capacity in patients with mild-to-moderate CHF. Neurohormones were favourably influenced by alacepril therapy, with significant decreases in plasma aldosterone, ANP and BNP levels[1]. |
Synonyms | Cetapril, DU-1219 |
Molecular Weight | 406.5 |
Formula | C20H26N2O5S |
CAS No. | 74258-86-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (67.65 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Alacepril 74258-86-9 Endocrinology/Hormones RAAS Cetapril antihypertensive effect DU1219 Inhibitor oral long lasting DU 1219 inhibit Angiotensin-converting Enzyme (ACE) DU-1219 inhibitor